Observational – PROSTATE WARRIORS – The latest news about prostate cancer

ASCO GU 2025: Impact of Homologous Recombination Repair Alterations on Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer (BRCA, ATM, CDK12,…)

February 14, 2025/in Observational, Retrospective studies/by Max

Discovery of WNT9B Gene Mutation Significantly Increases Prostate Cancer Risk

January 29, 2025/in Observational/by Max

Rethinking Treatment for mHSPC: Insights from Dr. Karim Fizazi

January 7, 2025/in Expert Insights, Observational, Retrospective studies/by Max

Retrospective study: Real-World Effectiveness of Apalutamide in mHSPC

January 7, 2025/in Observational, Retrospective studies/by Max

Where Are We With Ferroptosis?

December 29, 2024/in Observational, Post-hoc, Retrospective studies/by Max

New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients

December 20, 2024/in Observational, Post-hoc/by Max

Bone-Modifying Agents Linked to Improved Survival in Advanced Prostate Cancer

December 19, 2024/in Observational, Retrospective studies/by Max

Matching-Adjusted Comparison of PARPi Therapies for mCRPC: Talazoparib + Enzalutamide Wins

December 8, 2024/in Clinical Trial, Metastatic, Observational, Post-hoc, Retrospective studies/by Max

Rethinking the “Lower is Better” Approach to LDL-C: Examining the Relationship Between Low LDL-C and Prostate Cancer Risk in Non-Hypertensive Men

November 25, 2024/in Observational, Retrospective studies/by Max

The Role of HSD3B1 in Prostate Cancer Progression and Treatment

November 15, 2024/in Observational, Retrospective studies/by Max